In Veritas Medical Diagnostics, Inc. Stock
Equities
IVME
US45325A1007
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | -50.00% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Enjoy this offer
* See conditions on site
| Capitalization | 181K | P/E ratio 2006 |
-4.17x | P/E ratio 2007 | -0.08x |
|---|---|---|---|---|---|
| Enterprise value | 4.28M | EV / Sales 2006 |
6.15x | EV / Sales 2007 | - |
| Free-Float |
47.18% | Yield 2006 * |
-
| Yield 2007 | - |
More valuation ratios
* Estimated data
| 6 months | -98.00% | ||
| Current year | -50.00% |
1 month
0.00
0.00
Current year
0.000.01
1 year
0.000.01
3 years
0.000.01
5 years
0.000.09
10 years
0.000.09
| Director | Title | Age | Since |
|---|---|---|---|
David Ajemian
CEO | Chief Executive Officer | 45 | - |
Martin Thorp
DFI | Director of Finance/CFO | 72 | 05-04-25 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Ajemian
CEO | Chief Executive Officer | 45 | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -95.00% | -50.00% | 8.6K | ||
| +2.47% | +14.00% | -20.61% | +17.93% | 2.39B | ||
| +0.17% | +2.86% | +15.00% | -64.06% | 171M | ||
| -0.39% | +6.19% | -14.17% | -13.21% | 71.97M | ||
| +0.70% | -0.02% | -43.95% | -73.25% | 56.58M | ||
| Average | +0.59% | +4.45% | -31.75% | -36.52% | 538.6M | |
| Weighted average by Cap. | +2.21% | +12.77% | -18.66% | +9.97% |
Financials
(USD)| 2006 | 2007 | |
|---|---|---|
| Net sales | 1.27M | - |
| Net income | -1.85M | -3.67M |
| Net Debt | 3.05 | 4.1 |
More financial data
* Estimated data
Employees
8
- Stock Market
- Equities
- IVME Stock